Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 60,112 | 57,253 | 51,298 | 48,502 | 32,704 |
| Cost of Goods | 7,157 | 4,802 | 5,499 | 5,543 | 3,648 |
| Gross Profit | 52,955 | 52,451 | 45,799 | 42,959 | 29,056 |
| Operating Expenses | 105,473 | 100,316 | 98,951 | 88,798 | 76,708 |
| Operating Income | -52,361 | -47,063 | -52,653 | -45,296 | -47,004 |
| Interest Expense | 4,583 | 4,615 | 4,742 | 5,817 | 5,409 |
| Other Income | 1,850 | 4,142 | 4,602 | 4,818 | 2,995 |
| Pre-tax Income | -55,094 | -47,536 | -52,793 | -46,295 | -49,418 |
| Income Tax | 545 | -31 | 111 | 337 | 80 |
| Net Income Continuous | -55,639 | -47,505 | -52,904 | -46,632 | -49,498 |
| Net Income | $-55,639 | $-47,505 | $-52,904 | $-46,632 | $-49,498 |
| EPS Basic Total Ops | -0.83 | -0.73 | -0.82 | -0.75 | -0.81 |
| EPS Basic Continuous Ops | -0.82 | -0.71 | -0.80 | -0.73 | -0.78 |
| EPS Diluted Total Ops | -0.83 | -0.73 | -0.82 | -0.75 | -0.81 |
| EPS Diluted Continuous Ops | -0.82 | -0.71 | -0.80 | -0.73 | -0.78 |
| EPS Diluted Before Non-Recurring Items | -0.83 | -0.73 | -0.82 | -0.75 | -0.81 |
| EBITDA(a) | $-52,109 | $-46,791 | $-52,349 | $-44,917 | $-46,621 |